No, US EPA says in proposal

Facilities are reopening in China but spread of virus outside China is raising concerns

First Be(I) compounds to be crystallized could open up new main group chemistry

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on

Results for 2019 show resilience, but coronavirus impact shadows forecasts for this year

Substances will not undergo further evaluation of health and safety risks at this time

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on

First Be(I) compounds to be crystallized could open up new main-group chemistry

With Curie Co., the entrepreneur designs alternatives to compounds like parabens that have fallen out of favor with retailers

Her company, Biobot Analytics, is analyzing wastewater to give communities the information they need for the battle

Nobel Prize winner wants to solve real-world problems with directed evolution

DRT brings sustainable fragrance ingredients and industrial additives

Agency's approach for assessing risks to endangered species relies on real-world data

Mechanically chiral rotaxane creates a catalytic pocket a little like an enzyme

The past 10 years have been great for US ethylene producers, but they doubt a repeat performance

Scientists explore how to revamp the hair-thin silica glass fibers to transmit more and more data

Specialty chemical CEOs are rolling with the punches to keep their firms going

Chemical makers and oil producers are pulling back on production, reconsidering investments

Agency's approach for assessing risks to endangered species relies on real-world data

They persist in the pharma business, even as chemical companies in the West have mostly exited

Industry is deemed essential critical infrastructure by federal and state governments

Italian workers threaten to strike, but German, UK companies and workers pull together

The nucleoside inhibitor has advantages over Gilead's remdesivir but has yet to be tested in humans

Chemically distinct regions of alloys can help create strong yet flexible nanostructured metals

Activists say broad lack of enforcement threatens safety

Lingering logistic problems and a sputtering economy mean hard times for companies

Drugmakers want to keep trials going but acknowledge that medical resources are strained

Lingering logistic problems and a sputtering economy mean hard times for companies

Activists say broad lack of enforcement threatens safety

Stable organic radical replaces alkali metals or dissolving metal reductants in certain reactions

Artificial intelligence is helping us find novel, useful molecules. For the field to really take off, though, these tools will need to be accessible to the wider chemistry community

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease

As wipes and sprays sell out, quaternary ammonium compound makers try to keep up

Early earnings figures from chemical makers are down

Tests of 10 or more novel vaccines could be underway by mid-May

COVID-19 is driving a fivefold or greater increase in demand

Lab tests form part of the evidence for investigation and identification team's report

Members of the Division of Colloid and Surface Chemistry presented 155 virtual talks over 3 days